Sana Biotechnology, Inc. financial data

Symbol
SANA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
188 East Blaine Street, Suite 400, Seattle, WA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 469 % +28.6%
Debt-to-equity 87.3 % +14.2%
Return On Equity -94.5 % -41.3%
Return On Assets -50.5 % -33.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 223M shares +13.3%
Common Stock, Shares, Outstanding 223M shares +13.2%
Entity Public Float 600M USD -50%
Common Stock, Value, Issued 22K USD +10%
Weighted Average Number of Shares Outstanding, Basic 235M shares +19.5%
Weighted Average Number of Shares Outstanding, Diluted 235M shares +17.4%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 234M USD -13.4%
General and Administrative Expense 67.5M USD -10.9%
Operating Income (Loss) -312M USD -9.91%
Net Income (Loss) Attributable to Parent -306M USD -11%
Earnings Per Share, Basic -1.39 USD/shares +3.47%
Earnings Per Share, Diluted -1.39 USD/shares +3.47%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 127M USD -24.6%
Marketable Securities, Current 72M USD -28.1%
Assets, Current 210M USD -24.8%
Property, Plant and Equipment, Net 82.8M USD +21.1%
Operating Lease, Right-of-Use Asset 61M USD -21%
Intangible Assets, Net (Excluding Goodwill) 59.2M USD 0%
Goodwill 141M USD 0%
Other Assets, Noncurrent 5.56M USD -14.4%
Assets 559M USD -11.4%
Accounts Payable, Current 2.99M USD -69.9%
Employee-related Liabilities, Current 18.1M USD -25.7%
Liabilities, Current 47M USD -29.5%
Operating Lease, Liability, Noncurrent 85.5M USD +2.53%
Other Liabilities, Noncurrent 7.46M USD
Liabilities 267M USD +0.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 54K USD
Retained Earnings (Accumulated Deficit) -1.56B USD -24.5%
Stockholders' Equity Attributable to Parent 292M USD -20.1%
Liabilities and Equity 559M USD -11.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -65.6M USD +17.2%
Net Cash Provided by (Used in) Financing Activities 186M USD +78882%
Net Cash Provided by (Used in) Investing Activities -77.2M USD -223%
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 223M shares +13.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 43.5M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 131M USD -24.1%
Deferred Tax Assets, Valuation Allowance 403M USD +46.8%
Deferred Tax Assets, Gross 425M USD +42.2%
Operating Lease, Liability 96.1M USD -0.81%
Depreciation 23M USD +31.5%
Payments to Acquire Property, Plant, and Equipment 15.8M USD +628%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -306M USD -13.4%
Lessee, Operating Lease, Liability, to be Paid 176M USD -15%
Property, Plant and Equipment, Gross 136M USD +17.4%
Operating Lease, Liability, Current 10.6M USD -21.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 22.5M USD -11.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 21.8M USD -3.13%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 80.3M USD -12.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 19.9M USD -21.6%
Deferred Tax Assets, Operating Loss Carryforwards 192M USD +24.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 15.2M USD -23.5%
Additional Paid in Capital 1.85B USD +14.4%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 22.5M USD -9.02%
Share-based Payment Arrangement, Expense 39.2M USD +2.57%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%